【www.zhangdahai.com--企业文化建设】
[摘要] 目的：斯奇康注射液治疗常年性变应性鼻炎的疗效观察与评价。方法：83例患者，随机分为两组，治疗组局部鼻腔应用鼻用类固醇（辅舒良）联合应用斯奇康注射液；对照组单纯局部鼻腔应用鼻用类固醇（辅舒良）。结论：两组对比指标为临床症状及血清IgE变化。停止治疗1个月，两组对比指标差异无统计学意义（P＞0.05）；停止治疗2个月、3个月后两组对比指标差异有统计学意义（P＜0.05）。结果：斯奇康注射液佐治常年性变应性鼻炎的疗效值得肯定。
[关键词] 斯奇康；变应性鼻炎；鼻用类固醇
[中图分类号] R765.21[文献标识码]B [文章编号]1674-4721（2011）04（b）-067-02
Clinical evaluation of Skiller kang george perennial allergic rhinitis
CUI Ling, SONG Jie, ZHAO Liyang
The Friendship Hospital of Dalian City, Liaoning Province, Dalian 116011, China
[Abstract] Objective: To observe efficacy and evaluation of Siqikang injection in the treatment of perennial allergic rhinitis. Methods: 83 patients were randomly divided into two groups, the treatment group of local intranasal nasal steroids （Fu Shu Liang） combined Siqikang injection; the control group were treated with partial nasal nasal steroids (Fu Shu Liang). Conclusion: Indicators of clinical symptoms and changes in serum IgE between two groups. 1 month of treatment cessation, the two groups showed no statistically significant indicator（P>0.05）; stop for 2, 3 months, the index difference between two groups was significant（P
